Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001865094 | SCV002118975 | uncertain significance | not provided | 2024-05-05 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 73 of the PPP3CA protein (p.Arg73Gln). This variant is present in population databases (rs141696639, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of PPP3CA-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 1361019). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PPP3CA protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005023314 | SCV005659868 | uncertain significance | Developmental and epileptic encephalopathy 91; Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development | 2024-06-01 | criteria provided, single submitter | clinical testing |